Workers filing for Social Security Disability Insurance in 2026 face a higher earnings ceiling that doubles as a tripwire: anyone earning more than $1,690 a month can be turned away at the door, with no medical evidence ever reviewed. The Social Security Administration raised the Substantial Gainful Activity threshold for non-blind disabled individuals to that figure as part of its annual cost-of-living adjustment cycle, up from the 2025 level. The increase means more part-time earners now fall below the cutoff and can reach a medical review, but anyone above it still hits an automatic wall.
What is verified so far
The SSA’s Office of the Chief Actuary published the 2026 SGA amounts showing $1,690 per month for non-blind disabled workers and $2,830 per month for individuals who are statutorily blind, according to the agency’s official SGA table. A separate page in the agency’s Red Book for 2026 confirms the same $1,690 figure alongside a Trial Work Period service-month threshold of $1,210 per month, detailing how those dollar amounts interact with work incentives.
The stakes tied to that $1,690 line are spelled out in the agency’s own disability evaluation guidance. SSA uses a five-step sequential evaluation process codified in federal regulation. Step one asks a single question: is the claimant working at or above SGA? If the answer is yes, the claim ends right there. The agency’s plain-language explainer states that when someone is performing SGA, “SSA cannot consider you to have a qualifying disability and the sequential evaluation process ends at step 1,” according to the SSA’s disability evaluation page for adult claimants.
An SSA research note analyzing administrative data confirmed the same outcome from the agency’s internal records: claimants engaging in SGA are denied at step one without any consideration of medical criteria, according to a study from the Office of Retirement and Disability Policy. That means a person with a severe, documented condition can be rejected before a doctor’s report is opened, purely because monthly earnings crossed the line. For those who are already on the rolls and trying to work, SSA explains on its work incentives page that different rules apply, including trial work periods and extended eligibility, but those protections generally do not help new applicants at the initial step-one screen.
What remains uncertain
No 2026 administrative data yet shows how many claims are actually denied at step one near the new $1,690 threshold. The SSA has not published projections estimating how many additional applicants will clear step one solely because the higher SGA amount now places their earnings below the cutoff. Field office guidance on handling borderline earnings documentation for the updated limits has not been made public either, leaving open questions about how consistently the new ceiling will be applied across regions and adjudicators.
One tension in the agency’s own manuals deserves attention. The federal regulation states that if an individual is working and the work is SGA, SSA finds the individual not disabled at step one “regardless of medical condition,” per the Code of Federal Regulations. The agency’s internal Program Operations Manual, however, includes detailed instructions on how to evaluate whether earnings actually represent substantial work, allowing for adjustments based on subsidies from employers, impairment-related work expenses, and unsuccessful work attempts. Those internal rules can, in practice, reduce countable earnings below the formal SGA amount, but the precise frequency and consistency of such adjustments in 2026 adjudications are not yet documented in public data.
Advocates and claimants therefore enter 2026 with a clearer dollar figure but an incomplete picture of how it will play out in real cases. The verified numbers show that more low-wage and part-time workers should now clear the first procedural hurdle, at least on paper. What remains unknown is how many of them will actually see their claims move beyond step one, and how strictly SSA staff will interpret earnings that hover just above or below the $1,690 mark. Until the agency releases statistics on step-one outcomes under the new threshold, the line between a full medical review and an automatic denial will remain more visible in regulation than in lived experience.



